The Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: A Single-Center Real-World Study

MeSH terms

• Adenocarcinoma* / drug therapy
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Camptothecin / adverse effects
• Fluorouracil / adverse effects
• Humans
• Irinotecan / adverse effects
• Leucovorin / adverse effects
• Pancreatic Neoplasms* / pathology